{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T03:01:35Z","timestamp":1790650895707,"version":"4.1.0"},"reference-count":42,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Neurol"],"published-print":{"date-parts":[[2025,4,1]]},"abstract":"<jats:sec id=\"ab-noi240096-4\"><jats:title>Importance<\/jats:title><jats:p>To our knowledge, no randomized clinical trials have compared the efficacy and safety of teleneurorehabilitation (TNR) with in-person rehabilitation in Parkinson disease (PD) during the COVID-19 pandemic lockdown.<\/jats:p><\/jats:sec><jats:sec id=\"ab-noi240096-5\"><jats:title>Objective<\/jats:title><jats:p>To assess the efficacy and safety of TNR among patients with PD  during the COVID-19 lockdown.<\/jats:p><\/jats:sec><jats:sec id=\"ab-noi240096-6\"><jats:title>Design, Setting, and Participants<\/jats:title><jats:p>The TELEPARK single-center, assessor-blinded, randomized clinical trial was conducted over 11 months from September 2020 to July 2021, with follow-up after 12 weeks. Final data could be analyzed on July 1, 2024. Patients aged 18 years or older diagnosed with idiopathic PD with Hoehn and Yahr stage 1 to 2.5, Mini-Mental State Examination score of 24 or higher, and who possessed a smartphone allowing videocalling were eligible for inclusion and randomized to in-person or TNR therapy.<\/jats:p><\/jats:sec><jats:sec id=\"ab-noi240096-7\"><jats:title>Intervention<\/jats:title><jats:p>The in-person group received physiotherapy, aerobic, and breathing exercises for 30 minutes in person once a week for 4 weeks and then once every 2 weeks for 8 weeks. The TNR group received in-person sessions on day 1, followed by supervised sessions via videocalling once a week for the first 4 weeks, then once every 2 weeks for 8 weeks.<\/jats:p><\/jats:sec><jats:sec id=\"ab-noi240096-8\"><jats:title>Main Outcome and Measures<\/jats:title><jats:p>The primary outcome was mean change in the Movement Disorder Society\u2013Unified Parkinson\u2019s Disease Rating Scale III (MDS-UPDRS III) postintervention score from baseline. Mean changes in postintervention MDS-UPDRS II and III, Non-Motor Symptom Scale (NMSS), Parkinson\u2019s Disease Questionnaire-8 Summary Index (PDQ8-SI), 6-minute walk test (6MWT), and functional reach test (FRT) scores from baseline between groups was assessed using unpaired <jats:italic>t<\/jats:italic> tests.<\/jats:p><\/jats:sec><jats:sec id=\"ab-noi240096-9\"><jats:title>Results<\/jats:title><jats:p>A total of 63 participants (28 in-person and 35 TNR) were analyzed. Mean (SD) ages in the in-person and TNR groups were 60.50 (7.08) years and 62.80 (12.46) years, respectively. Twelve of 28 patients in the in-person group (42.9%) and 16 of 35 patients in the TNR group (45.7%) were female. Mean (SD) MDS-UPDRS III scores were significantly lower following TNR (pre-TNR: 35.17 [17.72] vs post-TNR: 28.6 [19.7]; <jats:italic>P<\/jats:italic>\u2009=\u2009.001). Mean (SD) change in postintervention MDS-UPDRS III scores was not significantly different between the 2 groups (TNR: \u22126.74 [11.07] vs in-person: \u22127.54 [10.52]; <jats:italic>P<\/jats:italic>\u2009=\u2009.39). Median changes in NMSS and PDQ8-SI scores were similar between the groups.<\/jats:p><\/jats:sec><jats:sec id=\"ab-noi240096-10\"><jats:title>Conclusions and Relevance<\/jats:title><jats:p>TNR is safe and effective in improving motor and nonmotor symptoms and quality of life among Indian patients with PD.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamaneurol.2024.5387","type":"journal-article","created":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T16:35:14Z","timestamp":1740414914000},"page":"376","source":"Crossref","is-referenced-by-count":10,"title":["Teleneurorehabilitation and Motor and Nonmotor Symptoms and Quality of Life in Parkinson Disease"],"prefix":"10.1001","volume":"82","author":[{"given":"Rajinder K.","family":"Dhamija","sequence":"first","affiliation":[{"name":"Department of Neurology, Lady Hardinge Medical College and Associated Hospitals, New Delhi, India"},{"name":"Now with Institute of Human Behaviour and Allied Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvee","family":"Saluja","sequence":"additional","affiliation":[{"name":"Department of Neurology, Lady Hardinge Medical College and Associated Hospitals, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divyani","family":"Garg","sequence":"additional","affiliation":[{"name":"Department of Neurology, Lady Hardinge Medical College and Associated Hospitals, New Delhi, India"},{"name":"Now with Department of Neurology, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonal","family":"Chauhan","sequence":"additional","affiliation":[{"name":"Department of Physical Medicine and Rehabilitation, Lady Hardinge Medical College and Associated Hospitals, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritu","family":"Majumdar","sequence":"additional","affiliation":[{"name":"Department of Physical Medicine and Rehabilitation, Lady Hardinge Medical College and Associated Hospitals, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shikha Bhatnagar","family":"Bhardwaj","sequence":"additional","affiliation":[{"name":"Department of Physical Medicine and Rehabilitation, Lady Hardinge Medical College and Associated Hospitals, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Preenja","sequence":"additional","affiliation":[{"name":"Department of Physical Medicine and Rehabilitation, Lady Hardinge Medical College and Associated Hospitals, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimple","family":"Kashyap","sequence":"additional","affiliation":[{"name":"Department of Physical Medicine and Rehabilitation, Lady Hardinge Medical College and Associated Hospitals, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayowa O.","family":"Owolabi","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Ibadan and University College Hospital Ibadan, Ibadan, Nigeria"},{"name":"Lebanese American University, Beirut, Lebanon"},{"name":"Blossom Specialist Medical Center, Ibadan, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"6","key":"noi240096r1","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S1474-4422(06)70471-9","article-title":"Epidemiology of Parkinson\u2019s disease.","volume":"5","author":"de Lau","year":"2006","journal-title":"Lancet Neurol"},{"issue":"5","key":"noi240096r2","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1212\/01.wnl.0000247740.47667.03","article-title":"Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030.","volume":"68","author":"Dorsey","year":"2007","journal-title":"Neurology"},{"issue":"12","key":"noi240096r3","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson\u2019s disease.","volume":"30","author":"Postuma","year":"2015","journal-title":"Movement Disord"},{"issue":"11","key":"noi240096r4","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1002\/mds.23135","article-title":"Parkinson\u2019s disease symptoms: the patient\u2019s perspective.","volume":"25","author":"Politis","year":"2010","journal-title":"Movement Disord"},{"key":"noi240096r5","doi-asserted-by":"publisher","first-page":"79","DOI":"10.4103\/AOMD.AOMD_1_20","article-title":"Rehabilitation in Parkinson\u2019s disease: current status and future directions.","volume":"3","author":"Garg","year":"2020","journal-title":"Ann Movement Disord"},{"key":"noi240096r6","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.jns.2016.02.017","article-title":"Neurotrophic factors in Parkinson\u2019s disease are regulated by exercise: evidence-based practice.","volume":"363","author":"da Silva","year":"2016","journal-title":"J Neurol Sci"},{"issue":"5","key":"noi240096r7","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.mehy.2015.07.011","article-title":"We need to move more: neurobiological hypotheses of physical exercise as a treatment for Parkinson\u2019s disease.","volume":"85","author":"Monteiro-Junior","year":"2015","journal-title":"Med Hypotheses"},{"issue":"7","key":"noi240096r8","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/S1474-4422(13)70123-6","article-title":"Exercise-enhanced neuroplasticity targeting motor and cognitive circuitry in Parkinson\u2019s disease.","volume":"12","author":"Petzinger","year":"2013","journal-title":"Lancet Neurol"},{"key":"noi240096r9","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.parkreldis.2020.09.003","article-title":"Impact of home confinement during COVID-19 pandemic on Parkinson\u2019s disease.","volume":"80","author":"Kumar","year":"2020","journal-title":"Parkinsonism Relat Disord"},{"issue":"2","key":"noi240096r10","doi-asserted-by":"publisher","first-page":"217","DOI":"10.4103\/aian.AIAN_1240_20","article-title":"The Impact of COVID-19 pandemic on disease severity and quality of life in Parkinson\u2019s disease.","volume":"24","author":"Saluja","year":"2021","journal-title":"Ann Indian Acad Neurol"},{"issue":"4","key":"noi240096r11","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1097\/WCO.0000000000000953","article-title":"The state of telemedicine for persons with Parkinson\u2019s disease.","volume":"34","author":"van den Bergh","year":"2021","journal-title":"Curr Opin Neurol"},{"issue":"2","key":"noi240096r12","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1044\/2015_AJSLP-15-0005","article-title":"Clinical and quality of life outcomes of speech treatment for Parkinson\u2019s disease delivered to the home via telerehabilitation: a noninferiority randomized controlled trial.","volume":"25","author":"Theodoros","year":"2016","journal-title":"Am J Speech Lang Pathol"},{"issue":"3","key":"noi240096r13","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1212\/CPJ.0000000000000252","article-title":"High patient satisfaction with telehealth in Parkinson disease: a randomized controlled study.","volume":"6","author":"Wilkinson","year":"2016","journal-title":"Neurol Clin Pract"},{"issue":"4","key":"noi240096r14","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1007\/s13760-022-02160-3","article-title":"Telerehabilitation during social distancing for people with Parkinson\u2019s disease: a retrospective study.","volume":"123","author":"Tardelli","year":"2023","journal-title":"Acta Neurol Belg"},{"key":"noi240096r15","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2024.106027","article-title":"Group tele-rehabilitation improves quality of life among subjects with Parkinson\u2019s disease: a two arm non-parallel non-randomized clinical trial.","volume":"121","author":"Sharma","year":"2024","journal-title":"Parkinsonism Relat Disord"},{"issue":"15","key":"noi240096r16","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1002\/mds.22340","article-title":"Movement Disorder Society-sponsored revision of the Unified Parkinson\u2019s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results.","volume":"23","author":"Goetz","year":"2008","journal-title":"Movement Disord"},{"key":"noi240096r17","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1080\/08870449708406741","article-title":"The PDQ-8: development and validation of a short-form Parkinson\u2019s disease questionnaire.","volume":"12","author":"Jenkinson","year":"1997","journal-title":"Psychol Health"},{"issue":"13","key":"noi240096r18","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1002\/mds.21596","article-title":"The metric properties of a novel non-motor symptoms scale for Parkinson\u2019s disease: results from an international pilot study.","volume":"22","author":"Chaudhuri","year":"2007","journal-title":"Mov Disord"},{"issue":"6329","key":"noi240096r19","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1136\/bmj.284.6329.1607","article-title":"Two-, six-, and 12-minute walking tests in respiratory disease.","volume":"284","author":"Butland","year":"1982","journal-title":"BMJ (Clin Res Ed)"},{"issue":"6","key":"noi240096r20","doi-asserted-by":"publisher","first-page":"M192","DOI":"10.1093\/geronj\/45.6.M192","article-title":"Functional reach: a new clinical measure of balance.","volume":"45","author":"Duncan","year":"1990","journal-title":"J Gerontol"},{"key":"noi240096r21","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.neubiorev.2019.10.015","article-title":"Stress-induced plasticity and functioning of ventral tegmental dopamine neurons.","volume":"108","author":"Douma","year":"2020","journal-title":"Neurosci Biobehav Rev"},{"issue":"12","key":"noi240096r22","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1089\/tmj.2020.0184","article-title":"Telemedicine in Parkinson\u2019s disease: how to ensure patient needs and continuity of care at the time of COVID-19 pandemic.","volume":"26","author":"Miele","year":"2020","journal-title":"Telemed J E Health"},{"key":"noi240096r23","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e5004","article-title":"Physiotherapy intervention in Parkinson\u2019s disease: systematic review and meta-analysis.","volume":"345","author":"Tomlinson","year":"2012","journal-title":"BMJ"},{"key":"noi240096r24","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.909197","article-title":"Feasibility, safety, and effectiveness of telerehabilitation in mild-to-moderate Parkinson\u2019s disease.","volume":"13","author":"Bianchini","year":"2022","journal-title":"Front Neurol"},{"key":"noi240096r25","doi-asserted-by":"publisher","DOI":"10.1177\/1756286420986744","article-title":"Effects of Lee Silverman Voice Treatment BIG and conventional physiotherapy on non-motor and motor symptoms in Parkinson\u2019s disease: a randomized controlled study comparing three exercise models.","volume":"14","author":"Schaible","year":"2021","journal-title":"Ther Adv Neurol Disord"},{"issue":"8","key":"noi240096r26","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1111\/ggi.12571","article-title":"Effect of health Baduanjin Qigong for mild to moderate Parkinson\u2019s disease.","volume":"16","author":"Xiao","year":"2016","journal-title":"Geriatr Gerontol Int"},{"issue":"1","key":"noi240096r27","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.parkreldis.2013.10.003","article-title":"Effects of a formal exercise program on Parkinson\u2019s disease: a pilot study using a delayed start design.","volume":"20","author":"Park","year":"2014","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"noi240096r28","first-page":"8","article-title":"Feldenkrais method-based exercise improves quality of life in individuals with Parkinson\u2019s disease: a controlled, randomized clinical trial.","volume":"21","author":"Teixeira-Machado","year":"2015","journal-title":"Altern Ther Health Med"},{"issue":"2","key":"noi240096r29","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1093\/gerona\/58.2.M176","article-title":"Aerobic fitness reduces brain tissue loss in aging humans.","volume":"58","author":"Colcombe","year":"2003","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"8","key":"noi240096r30","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1016\/j.neurobiolaging.2011.05.010","article-title":"Resistance training and functional plasticity of the aging brain: a 12-month randomized controlled trial.","volume":"33","author":"Liu-Ambrose","year":"2012","journal-title":"Neurobiol Aging"},{"issue":"3","key":"noi240096r31","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1080\/13682820802033968","article-title":"Delivering the Lee Silverman Voice Treatment (LSVT) by web camera: a feasibility study.","volume":"44","author":"Howell","year":"2009","journal-title":"Int J Lang Commun Disord"},{"issue":"4","key":"noi240096r32","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1080\/17549507.2018.1476918","article-title":"Delivering group speech maintenance therapy via telerehabilitation to people with Parkinson\u2019s disease: a pilot study.","volume":"21","author":"Quinn","year":"2019","journal-title":"Int J Speech Lang Pathol"},{"issue":"1","key":"noi240096r33","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1097\/MRR.0000000000000205","article-title":"Clinical utility of the 6-min walk test for patients with moderate Parkinson\u2019s disease.","volume":"40","author":"Kobayashi","year":"2017","journal-title":"Int J Rehabil Res"},{"issue":"6","key":"noi240096r34","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/j.apmr.2008.12.018","article-title":"Six-minute walk distance in persons with Parkinson disease: a hierarchical regression model.","volume":"90","author":"Falvo","year":"2009","journal-title":"Arch Phys Med Rehabil"},{"issue":"1","key":"noi240096r35","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1097\/NPT.0000000000000111","article-title":"Highly challenging balance program reduces fall rate in Parkinson disease.","volume":"40","author":"Sparrow","year":"2016","journal-title":"J Neurol Phys Ther"},{"key":"noi240096r36","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/241754","article-title":"Impaired economy of gait and decreased six-minute walk distance in Parkinson\u2019s disease.","volume":"2012","author":"Katzel","year":"2012","journal-title":"Parkinsons Dis"},{"issue":"2","key":"noi240096r37","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.expneurol.2004.12.008","article-title":"Direction-specific postural instability in subjects with Parkinson\u2019s disease.","volume":"193","author":"Horak","year":"2005","journal-title":"Exp Neurol"},{"key":"noi240096r38","doi-asserted-by":"publisher","first-page":"286","DOI":"10.3389\/fnagi.2014.00286","article-title":"Instrumented functional reach test differentiates individuals at high risk for Parkinson\u2019s disease from controls.","volume":"6","author":"Hasmann","year":"2014","journal-title":"Front Aging Neurosci"},{"key":"noi240096r39","doi-asserted-by":"publisher","DOI":"10.4025\/jphyseduc.v28i1.2846","article-title":"Predictors of the functional reach test in people with parkinson\u2019s disease.","volume":"28","author":"de Morais","year":"2017","journal-title":"J Phys Educ (Maring\u00e1)"},{"key":"noi240096r40","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/7962826","article-title":"Virtual reality telerehabilitation for postural instability in Parkinson\u2019s disease: a multicenter, single-blind, randomized, controlled trial.","volume":"2017","author":"Gandolfi","year":"2017","journal-title":"Biomed Res Int"},{"issue":"8","key":"noi240096r41","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1177\/1357633X16668092","article-title":"Feasibility and preliminary efficacy of a telerehabilitation approach to group adapted tango instruction for people with Parkinson disease.","volume":"23","author":"Seidler","year":"2017","journal-title":"J Telemed Telecare"},{"issue":"4","key":"noi240096r42","doi-asserted-by":"publisher","first-page":"536","DOI":"10.4103\/aian.AIAN_127_21","article-title":"Teleneurorehabilitation among person with Parkinson\u2019s disease in India: the initial experience and barriers to implementation.","volume":"24","author":"Garg","year":"2021","journal-title":"Ann Indian Acad Neurol"}],"container-title":["JAMA Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/articlepdf\/2830411\/jamaneurology_dhamija_2025_oi_240096_1743609746.21161.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T15:01:01Z","timestamp":1744642861000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/fullarticle\/2830411"}},"subtitle":["The TELEPARK Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2025,4,1]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaneurol.2024.5387","relation":{},"ISSN":["2168-6149"],"issn-type":[{"value":"2168-6149","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4,1]]}}}